Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c390 |
|---|---|
| Identifier | NCT06681181 |
| Trial Title | A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: GSK4528287|DRUG: Placebo |
Participant Information
| Sponsor | GlaxoSmithKline |
|---|---|
| City | Cambridge |
| Country/Region | United Kingdom |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2024-11-18 |
|---|---|
| Primary Completion Date | 2026-04-23 |
| Completion Date | 2027-02-25 |